0001209191-18-053533.txt : 20181002
0001209191-18-053533.hdr.sgml : 20181002
20181002213532
ACCESSION NUMBER: 0001209191-18-053533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180928
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASTRAZENECA PLC
CENTRAL INDEX KEY: 0000901832
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103591
BUSINESS ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
BUSINESS PHONE: 011 44 20 7304 5000
MAIL ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
FORMER NAME:
FORMER CONFORMED NAME: ZENECA GROUP PLC
DATE OF NAME CHANGE: 19930422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASTRAZENECA AB
CENTRAL INDEX KEY: 0000928966
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 181103592
BUSINESS ADDRESS:
STREET 1: V?STRA M?LAREHAMNEN 9
CITY: S?DERT?LJE
STATE: V7
ZIP: SE-151 85
BUSINESS PHONE: 0044 (0) 20 7604 800
MAIL ADDRESS:
STREET 1: V?STRA M?LAREHAMNEN 9
CITY: S?DERT?LJE
STATE: V7
ZIP: SE-151 85
FORMER NAME:
FORMER CONFORMED NAME: ASTRA AB
DATE OF NAME CHANGE: 19981116
FORMER NAME:
FORMER CONFORMED NAME: ASTRA AKTIEBOLAG
DATE OF NAME CHANGE: 19960718
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001724344
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824592913
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 810-0120
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Entasis Therapeutics Ltd
DATE OF NAME CHANGE: 20171204
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-28
0
0001724344
Entasis Therapeutics Holdings Inc.
ETTX
0000901832
ASTRAZENECA PLC
1 FRANCIS CRICK AVENUE
CAMBRIDGE
X0
CB2 0AA
UNITED KINGDOM
0
0
1
0
0000928966
ASTRAZENECA AB
C/O ASTRAZENECA PLC
1 FRANCIS CRICK AVENUE
CAMBRIDGE
X0
CB2 0AA
UNITED KINGDOM
0
0
1
0
Common Stock
2018-09-28
4
C
0
1918185
A
1918189
I
See Footnote
Common Stock
2018-09-28
4
P
0
246666
15.00
A
2164855
I
See Footnote
Series A Preferred Stock
2018-09-28
4
C
0
33499900
0.00
D
Common Stock
1616166
0
I
See Footnote
This number includes 302,019 shares of Common Stock received upon the conversion of the Issuer's Series A Preferred Stock as payment of accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018.
Each share of Series A Preferred Stock automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.
All of these securities are owned by AstraZeneca AB, which is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by AstraZeneca AB, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. The principal business address of AstraZeneca AB is SE-151 85 Sodertalje, Sweden.
/s/ Adrian Kemp, Company Secretary of AstraZeneca PLC
2018-10-02
/s/ Yvonne Bertlin, Authorized Signatory of AstraZeneca AB
2018-10-02